The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Open accessAbstract
BACKGROUND: In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B6 and B12 lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease. METHODS: We randomly assigned 5522 patients 55 years of age or older who had vascular disease or diabetes to daily treatment either with the combination of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12 or with placebo for an average of five years. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, and stroke. RESULTS: Mean plasma homocysteine levels decreased by 2.4 micromol per liter (0.3 mg per liter) in the active-treatment group and increased by 0.8 micromol per liter (0.1 mg per liter) in the placebo group. Primary outcome events occurred in 519 patients (18.8 percent) assigned to active therapy and 547 (19.8 percent) assigned to placebo (relative risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P=0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). CONCLUSIONS: Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,945
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., & Schouten, E. G. (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 932
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Dietary methyl-consuming compounds and metabolic syndrome
Zhou, S., Zhou, Y., Li, D., & Lun, Y. (2011) · Hypertension Research · doi:10.1038/hr.2011.133 · Cited by 44
Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection
Erkens, R., Suvorava, T., Sutton, T. R., Fernandez, B. O., Mikus-Lelinska, M., Barbarino, F., Flögel, U., Kelm, M., Feelisch, M., & Cortese-Krott, M. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8309698 · Cited by 43
Homocysteine increases the risk of mortality in elderly individuals
González, S., Huerta, J. M., Fernández, S., Patterson, Á. M., & Lasheras, C. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507691958 · Cited by 44
Zhang, Y., & Ning, G. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.953 · Cited by 45
Should folic acid fortification be mandatory? Yes
Wald, N., & Oakley, G. P. (2007) · BMJ · doi:10.1136/bmj.39232.493252.47 · Cited by 43
Blood profile of oral mucosal disease patients with both vitamin B12 and iron deficiencies
Chang, J. Y., Wang, Y., Wu, Y., Cheng, S., Chen, H., & Sun, A. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.03.002 · Cited by 43
“acid deficiency can lead to high homocysteine levels in their sera.(21,22) Moreover, the high blood homocysteine levels in patients was found to be due to deficiencies in folic acid, vitamin B12, and vitamin B6, because a supplement therapy with folic acid, vitamin B12, and vitamin B6 can reduce blood homocysteine lev…”
BackgroundInfluentialModulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging
Choi, S., & Friso, S. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.4.597 · Cited by 49
Interventions for lowering plasma homocysteine levels in dialysis patients
Nigwekar, S. U., Kang, A., Zoungas, S., Cass, A., Gallagher, M., Kulshrestha, S., Navaneethan, S. D., Perkovic, V., Strippoli, G. F., & Jardine, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004683.pub4 · Cited by 43
Kwok, T. C. Y., Chook, P., Qiao, M., Tam, L., Poon, Y. K. P., Ahuja, A. T., Woo, J., Celermajer, D. S., & Woo, K. S. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0036-x · Cited by 43
Bochyńska, A., Lipczyńska-Łojkowska, W., Gugała-Iwaniuk, M., Lechowicz, W., Restel, M., Graban, A., Lipska-Ziętkiewicz, B. S., & Ryglewicz, D. (2012) · Seizure · doi:10.1016/j.seizure.2012.01.013 · Cited by 42
Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis
Kimball, A. B., & Wu, Y. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.04075.x · Cited by 43
Novel Therapies Targeting Vascular Endothelium
Tousoulis, D., Antoniades, C. A., Κούμαλλος, Ν., Marinou, K., Stefanadi, E., Latsios, G., & Stefanadis, C. (2006) · Endothelium · doi:10.1080/10623320601061714 · Cited by 42
Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?
Carroll, B., & Piazza, G. (2018) · Vascular Medicine · doi:10.1177/1358863x18755927 · Cited by 44
Ryan-Harshman, M., & Aldoori, W. H. (2008) · PubMed Central · Cited by 43
Stea, T. H., Mansoor, M. A., Wandel, M., Uglem, S., & Frølich, W. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0714-y · Cited by 41
The Genetics of Vascular Complications in Diabetes Mellitus
Farbstein, D., & Levy, A. P. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.005 · Cited by 43
Qiu, L., Sun, Y., Wang, L., Han, R., Xia, X., Liu, J., & Li, X. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.037 · Cited by 43
Kessler, M., Zannad, F. M., Lehert, P., Grünfeld, J., Thuilliez, C., Leizorovicz, A., Lechat, P. P., & for the FOSIDIAL Investigators (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm417 · Cited by 43
Gommans, J., Yi, Q., Eikelboom, J. W., Hankey, G. J., Chen, C., & Rodgers, H. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-88 · Cited by 42
Pan, Y., Guo, L., Cai, L. L., Zhu, X. J., Shu, J. L., Liu, X. L., & Jin, H. M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114511007033 · Cited by 42
Rodionov, R. N., Dayoub, H., Lynch, C. M., Wilson, K. M., Stevens, J. W., Murry, D. J., Kimoto, M., Arning, E., Bottiglieri, T., Cooke, J. P., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.200360 · Cited by 42
Bostom, A. G., Carpenter, M. A., Hunsicker, L. G., Jacques, P. F., Kusek, J. W., Levey, A. S., McKenney, J. L., Mercier, R. Y., Pfeffer, M. A., & Selhub, J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.010 · Cited by 42
Zhou, X., Liu, J.-X., Shi, R., Yang, N., Song, D.-L., Pang, W., & Li, Y. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.135 · Cited by 43
Reynolds, E. H. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.231 · Cited by 42
Cohen, E., Margalit, I., Shochat, T., Goldberg, E., & Krause, I. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00618-x · Cited by 42
An eicosanoid-centric view of atherothrombotic risk factors
Gleim, S., Stitham, J., Tang, W. H., Martin, K. A., & Hwa, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0982-9 · Cited by 43
Johnston, R. B. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31815b8ec5 · Cited by 40
Rodionov, R. N., & Lentz, S. R. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164830 · Cited by 43
Whayne, T. F. (2014) · Angiology · doi:10.1177/0003319714548871 · Cited by 42
“Lonn et al, in the Heart Outcomes Prevention Evaluation (HOPE) 2 study involving 5522 patients 55 years with vascular disease or DM, found that the supplement combination of folic acid, vitamin B6, and vitamin B12 did not decrease major CV events.(22) This result occurred in spite of the 2.”
BackgroundKuo, Y., Chang, J. Y., Wang, Y., Wu, Y., Wu, Y.-H., & Sun, A. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.04.007 · Cited by 41
Sabino, A. D. P., Fernandes, A. P., Lima, L. M., Ribeiro, D. D., Sousa, M. O., Santos, M. E. R. D. C., Mota, A. P. L., Dusse, L. M. S., & Ferriani, M. D. G. C. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0172-z · Cited by 40
van Gils, P. F., Over, E. A. B., Reenen, H. H. H.-V., de Wit, G. A., van den Berg, M., Schuit, A. J., & Engelfriet, P. M. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000363 · Cited by 41
Kesherwani, V., Nandi, S. S., Sharawat, S. K., Shahshahan, H. R., & Mishra, P. K. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2383-5 · Cited by 41
Kozłowska−Wojciechowska, M. (2013) · Medical Science Monitor · doi:10.12659/msm.889087 · Cited by 41
Galan, P., Briançon, S., Blacher, J., Czernichow, S., & Herçberg, S. (2008) · Trials · doi:10.1186/1745-6215-9-35 · Cited by 41
Dietary folates and cancer risk in a network of case–control studies
Tavani, A., Malerba, S., Pelucchi, C., Maso, L. D., Zucchetto, A., Serraino, D., Levi, F., Montella, M., Franceschi, S., Zambon, A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds212 · Cited by 41
Genetic determinants of C-reactive protein
Danik, J. S., & Ridker, P. M. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0019-2 · Cited by 42
“For example, mendelian randomization has claimed to prove that homocysteine is causal for cardiovascular disease [77], but randomized trials have shown that reducing homocysteine has no effect on outcomes [ 78 ].”
BackgroundZhang, C., Wang, Z., Qin, Y., Yu, F., & Zhou, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107060 · Cited by 41
Bailey, L. B., & Caudill, M. A. (2012) · Wiley eBooks · doi:10.1002/9781119946045.ch21 · Cited by 41
Malinowska, A. M., & Chmurzyńska, A. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.09.018 · Cited by 40
Park, J., Saposnik, G., Ovbiagele, B., Markovic, D., & Towfighi, A. (2016) · International Journal of Stroke · doi:10.1177/1747493015616512 · Cited by 40
“The Heart Outcomes Prevention Evaluation (HOPE) 2 trial evaluated whether folic acid, pyridoxine, and cobalamin, reduced the risk of death from cardiovascular causes, myocardial infarction, and stroke among 5522 individuals aged 55 years with pre-existing coronary, cerebrovascular or peripheral vascular disease, or di…”
BackgroundInfluentialNHG-Standaard Cardiovasculair risicomanagement
Wiersma, T., Boukes, F., Geijer, R. M. M., & Goudswaard, A. N. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_6 · Cited by 40
Woolf, K., & Manore, M. M. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.12.001 · Cited by 41
Dankner, R. S., Chetrit, A., Ken‐Dror, G., & Sela, B. (2007) · AGE · doi:10.1007/s11357-007-9041-0 · Cited by 40
“…B supplementation for high risk populations has increased since the publication of clinical trials which failed to reduce CVD events (Bonaa et al. 2006; Toole et al. 2004; Lonn et al 2006) or improve cognitive performance while reducing Hcy levels via those supplementations (McMahon et al. 2006).”
BackgroundRisk factors for ischemic stroke and transient ischemic attack in patients under age 50
Janssen, A. W. M., de Leeuw, F., & Janssen, M. C. H. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0491-3 · Cited by 41
Nutrient supplements and cardiovascular disease: a heartbreaking story
Lichtenstein, A. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800027-jlr200 · Cited by 42
Vitamin B6 and Cardiovascular Disease
Friso, S., Lotto, V., Corrocher, R., & Choi, S. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2199-9_14 · Cited by 41
Heart disease and single-vitamin supplementation
Traber, M. G. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.293s · Cited by 39
Wu, Y.-H., Chang, J. Y., Wang, Y., Wu, Y., Chen, H., & Sun, A. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.03.005 · Cited by 39
Williams, K. J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320065 · Cited by 41
Folate, vitamin B12 and homocysteine status in an Italian blood donor population
Zappacosta, B., Persichilli, S., Iacoviello, L., Castelnuovo, A. F. D., Graziano, M., Gervasoni, J., Leoncini, E., Cimino, G. G., & Mastroiacovo, P. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.10.001 · Cited by 39
Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand?
Messina, M. J., & Lane, B. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.55 · Cited by 39
“Furthermore, it is important to note that recent clinical data call into question the benefit of reducing homocysteine levels for lowering the risk of CHD [163–165].”
BackgroundLiu, D., Wang, S.-L., Li, J., Liang, E., Yan, M.-Z., & Gao, W. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4698 · Cited by 39
Folic Acid Supplement Use and Increased Risk of Gestational Hypertension
Li, Q., Xu, S., Chen, X., Zhang, X., Li, X., Lin, L., Gao, D., Wu, M., Yang, S., Cao, X., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14621 · Cited by 40
Held, C., Sumner, G., Sheridan, P., McQueen, M. J., Smith, S. L., Dagenais, G. R., Yusuf, S., & Lonn, E. (2008) · Vascular Medicine · doi:10.1177/1358863x08092102 · Cited by 39
do Rosario, V. A., Fernandes, R., & Trindade, E. B. S. D. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw012 · Cited by 43
Horizons in Nutritional Science
Otto, B., Spranger, J., Benoit, S. C., Clegg, D. J., & Tschöp, M. H. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051446 · Cited by 39
Plasma Vitamin B 6 and Risk of Myocardial Infarction in Women
Page, J. H., Ma, J., Chiuve, S. E., Stampfer, M. J., Selhub, J., Manson, J. E., & Rimm, E. B. (2009) · Circulation · doi:10.1161/circulationaha.108.809038 · Cited by 37
Guelpen, B. R. V., Dahlin, A. M., Hultdin, J., Eklöf, V., Johansson, I., Henriksson, M. L., Cullman, I., Hallmans, G., & Palmqvist, R. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9484-y · Cited by 38
Zawada, A. M., Rogacev, K. S., Hummel, B., Berg, J. T., Friedrich, A., Roth, H. J., Obeid, R., Geisel, J., Fliser, D., & Heine, G. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.002 · Cited by 38
Tu, W., Yan, F., Chao, B., Ji, X., & Wang, L. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0871-4 · Cited by 40
Hereditary Coagulopathies: Practical Diagnosis and Management for the Plastic Surgeon
Friedman, T., Coon, D., Michaels, J., Bontempo, F. A., Young, V. L., Clavijo, J. A., & Rubin, J. P. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181d51344 · Cited by 38
Henkel, A. S., Elias, M. S., & Green, R. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017970 · Cited by 37
Venous thromboembolism in association with features of the metabolic syndrome
Ray, J. G., Lonn, E., Yi, Q., Rathe, A., Sheridan, P., Kearon, C., & on behalf of the HOPE-2 investigators (2007) · QJM · doi:10.1093/qjmed/hcm083 · Cited by 38
Carr, D. F., Whiteley, G., Alfirevic, A., Pirmohamed, M., & on behalf of the FolATED study team (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.29 · Cited by 41
Fuentes, B., Gállego, J., Gil-Núñez, A., Morales, A., Purroy, F. F., Roquer, J., Segura, T., Tejada, J., Lago, A. P., Díez‐Tejedor, E., et al. (2011) · Neurología · doi:10.1016/j.nrl.2011.06.002 · Cited by 39
Husemoen, L. L. N., Skaaby, T., Jørgensen, T., Thuesen, B. H., Fenger, M., Grarup, N., Sandholt, C. H., Hansen, T. F., Pedersen, O. B., & Linneberg, A. R. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0659-2 · Cited by 37
Ueland, P. M., & Clarke, R. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.085480 · Cited by 37
Vanuzzo, D., Pilotto, L., Lombardi, R., Lazzerini, G., Carluccio, M. A., Diviacco, S., Quadrifoglio, F., Danek, G. M., Gregori, D., Fioretti, P., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl470 · Cited by 37
Korai, M., Kitazato, K. T., Tada, Y., Miyamoto, T., Shimada, K., Matsushita, N., Kanematsu, Y., Satomi, J., Hashimoto, T. N., & Nagahiro, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0634-3 · Cited by 38
Homocysteine and Cardiovascular Disease
Barter, P. J., & Rye, K. (2006) · Circulation Research · doi:10.1161/01.res.0000243583.39694.1f · Cited by 38
Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies
Dunn, S. P., Bleske, B. E., Dorsch, M. P., Macaulay, T. E., Tassell, B. W. V., & Vardeny, O. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533608329299 · Cited by 36
Spence, J. D. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.114 · Cited by 36
Qin, X., Shen, L., Zhang, R., Li, Y., Wang, X., Wang, B., Jiang, X., Jiang, H., Yu, L., Hou, F. F., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30094 · Cited by 36
Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation
Suvorava, T., Nagy, N., Pick, S., Lieven, O., Rüther, U., Dao, V. T.-V., Fischer, J. W., Weber, M., & Kojda, G. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6059 · Cited by 36
Karaźniewicz‐Łada, M., & Główka, A. K. (2015) · Journal of Separation Science · doi:10.1002/jssc.201501038 · Cited by 36
Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia
Dayal, S., Chauhan, A. K., Jensen, M. J., Leo, L., Lynch, C. M., Faraci, F. M., Kruger, W. D., & Lentz, S. R. (2011) · Blood · doi:10.1182/blood-2011-09-380568 · Cited by 36
Wald, N., & Wald, D. S. (2009) · Postgraduate Medical Journal · doi:10.1136/hrt.2009.186429 · Cited by 36
Human Pathway-Based Disease Network
Yu, L., & Gao, L. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2774802 · Cited by 35
Keating, A. K., Freehauf, C. L., Jiang, H., Brodsky, G. L., Stabler, S. P., Allen, R. H., Graham, D. K., Thomas, J. A., Hove, J. L. K. V., & Maclean, K. N. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.012 · Cited by 33
der Zee, A. H. M., Lynch, A. I., Boerwinkle, E., Arnett, D. K., Davis, B. R., Leiendecker‐Foster, C., Ford, C. E., & Eckfeldt, J. H. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282fe1759 · Cited by 35
Pounis, G., Castelnuovo, A. F. D., de Lorgeril, M., Krogh, V., Siani, A., Arnout, J., Cappuccio, F. P., DONGEN, M. C. J. M. V., Zappacosta, B., Donati, M. B., et al. (2013) · Nutrition · doi:10.1016/j.nut.2013.11.014 · Cited by 35
Carey, K. M., Cornee, M. R., Donovan, J. L., & Kanaan, A. O. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q621 · Cited by 35
Lightfoot, T. J., Barrett, J. H., Bishop, D. T., Northwood, E. L., Smith, G. C., Wilkie, M. J. V., Steele, R. J., Carey, F. A., Key, T. J., Wolf, C. R., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0058 · Cited by 34
Lee, H., Kim, S. Y., & Sok, S. R. (2016) · Journal of Nursing Scholarship · doi:10.1111/jnu.12201 · Cited by 35
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
DeLoughery, T. G., Hunt, B. J., Barnes, G. D., Connors, J. M., Ay, C., Barco, S., Castellucci, L. A., Cesarman-Maus, G. N., Paula, E. V. D., Dumantepe, M., et al. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12739 · Cited by 34
A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome
Seneff, S., Davidson, R. M., Lauritzen, A., Samsel, A., & Wainwright, G. (2015) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-015-0006-1 · Cited by 36
Spence, J. D. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0020-8 · Cited by 34
Human in vivo research on the vascular effects of adenosine
Riksen, N. P., Rongen, G. A. P. J. M., Yellon, D. M., & Smits, P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.053 · Cited by 34
B-vitamins, genotype and disease causality
Haggarty, P. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005861 · Cited by 34
Low vitamin B6 levels and the risk of recurrent venous thromboembolism
Hron, G., Lombardi, R., Eichinger, S., Lecchi, A., Kyrle, P. A., & Cattaneo, M. (2007) · Haematologica · doi:10.3324/haematol.11318 · Cited by 34
Chen, S., Wu, P., Zhou, L., Shen, Y., Li, Y., & Song, H. (2015) · Europe PMC (PubMed Central) · Cited by 35
Plasma Homocysteine in Patients with Retinal Vein Occlusion
Minniti, G., Calevo, M. G., Giannattasio, A., Camicione, P., Armani, U., Lorini, R., & Piana, G. (2014) · European Journal of Ophthalmology · doi:10.5301/ejo.5000426 · Cited by 34
Primary and Secondary Prevention of Coronary Heart Disease
Gaziano, J. M., Ridker, P. M., & Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00049-4 · Cited by 34
Management of inherited thrombophilia in pregnancy
Ormesher, L., Simcox, L. E., Tower, C. L., & Greer, I. A. (2016) · Women s Health · doi:10.1177/1745505716653702 · Cited by 35
Li, K. J., Borresen, E. C., Puccetti, N., Luckasen, G. J., & Ryan, E. P. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00071 · Cited by 34
Ebrahimpour, A., Vaghari‐Tabari, M., Qujeq, D., Moein, S., & Moazezi, Z. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.05.002 · Cited by 34
Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study
Spratlen, M. J., Grau-Pérez, M., Umans, J. G., Yracheta, J., Best, L. G., Francesconi, K. A., Goessler, W., Balakrishnan, P., Cole, S. A., Gamble, M. V., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.09.048 · Cited by 34
Association between serum folate and cardiovascular deaths among adults with hypertension
Nkemjika, S., Ifebi, E., Cowan, L., Fung, I. C., Twum, F., Liu, F., & Zhang, J. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0533-7 · Cited by 34
Metadata
- Authors
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-13
- Volume
- 354
- Issue
- 15
- Pages
- 1567-1577
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109544293
- Cited by
- 1,729
- References
- 20
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 33 · 2023: 30 · 2022: 43 · 2021: 37 · 2020: 52 · 2019: 46 · 2018: 46 · 2017: 70 · 2016: 81 · 2015: 77 · 2014: 84 · 2013: 85 · 2012: 104
- FWCI
- 136.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Massachusetts Medical Society
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- homocysteine lowering, folic acid, vitamin B6, vitamin B12, vascular disease, cardiovascular events, stroke, myocardial infarction, cardiovascular mortality, unstable angina, diabetes mellitus, older adults
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Vascular Diseases, Vitamin B 12, Hyperhomocysteinemia, Stroke, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
